Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Analytical Biochemistry|December 6, 2003
Development of a fluorescence polarization assay to screen for inhibitors of the FtsZ/ZipA interactionCynthia Hess Kenny, Weidong Ding, Kerry Kelleher, et al.Protein Engineering, Design & Selection : PEDS|January 23, 2025
Engineering of a lysosomal-targeted GAA enzymeNicholas Marze, Ilya Tikh, Susan Benard, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: protection from ischemia-reperfusion injury in liver transplantationSei-ichiro Tsuchihashi, Constantino Fondevila, Gray D Shaw, et al.Mabs|September 15, 2016
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibodyJames R Apgar, Michelle Mader, Rita Agostinelli, et al.The Journal of Biological Chemistry|September 29, 2006
The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibitionLidia Mosyak, Andrew Wood, Brian Dwyer, et al.Scientific Reports|April 27, 2021
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulationElla Fung, Liya Kang, Diana Sapashnik, et al.Blood|January 4, 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemiaJoão Arezes, Niall Foy, Kirsty McHugh, et al.Antibodies (Basel, Switzerland)|September 28, 2019
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.Pageof 1